Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography by Walter Koch, Christoph J. Auernhammer, Julia Geisler, Christine Spitzweg, Clemens C. Cyran, Harun Ilhan, Peter Bartenstein, Alexander R. Haug

Get full text

Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. by Julia Diegelmann, Florian Beigel, Kathrin Zitzmann, Artur Kaul, Burkhard Göke, Christoph J Auernhammer, Ralf Bartenschlager, Helmut M Diepolder, Stephan Brand

Get full text

Molecular Imaging with ¹⁸F-FDG PET/CT and ^99mTc-MIBI SPECT/CT in Osteitis Fibrosa Cystica Generalisata by Adrien Holzgreve, Matthias P. Fabritius, Thomas Knösel, Lena M. Mittlmeier, Johannes Rübenthaler, Reinhold Tiling, Christoph J. Auernhammer, Peter Bartenstein, Marcus Unterrainer

Get full text

Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters by Maria Ingenerf, Sophia Kiesl, Michael Winkelmann, Christoph J. Auernhammer, Johannes Rübenthaler, Freba Grawe, Matthias P. Fabritius, Jens Ricke, Christine Schmid-Tannwald

Get full text

Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs by Freba Grawe, Natalie Rosenberger, Maria Ingenerf, Leonie Beyer, Ralf Eschbach, Andrei Todica, Ricarda Seidensticker, Christine Schmid-Tannwald, Clemens C. Cyran, Jens Ricke, Peter Bartenstein, Christoph. J. Auernhammer, Johannes Ruebenthaler, Matthias P. Fabritius

Get full text

Cost-Effectiveness Analysis of ⁶⁸Ga DOTA-TATE PET/CT, ¹¹¹In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors by Matthias Frank Froelich, Moritz Ludwig Schnitzer, Adrien Holzgreve, Felix Gerhard Gassert, Eva Gresser, Daniel Overhoff, Vincent Schwarze, Matthias Philipp Fabritius, Dominik Nörenberg, Niklas von Münchhausen, Nils Große Hokamp, Christoph J. Auernhammer, Harun Ilhan, Andrei Todica, Johannes Rübenthaler

Get full text

The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models. by Svenja Nölting, Jakob Rentsch, Helma Freitag, Katharina Detjen, Franziska Briest, Markus Möbs, Victoria Weissmann, Britta Siegmund, Christoph J Auernhammer, Elke Tatjana Aristizabal Prada, Michael Lauseker, Ashley Grossman, Samantha Exner, Christian Fischer, Carsten Grötzinger, Jörg Schrader, Patricia Grabowski, GERMAN NET-Z study group

Get full text

Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE by Ralf S. Eschbach, Markus Hofmann, Lukas Späth, Gabriel T. Sheikh, Astrid Delker, Simon Lindner, Klaus Jurkschat, Carmen Wängler, Björn Wängler, Ralf Schirrmacher, Reinhold Tiling, Matthias Brendel, Vera Wenter, Franziska J. Dekorsy, Mathias J. Zacherl, Andrei Todica, Andrei Todica, Harun Ilhan, Harun Ilhan, Freba Grawe, Freba Grawe, Clemens C. Cyran, Marcus Unterrainer, Johannes Rübenthaler, Thomas Knösel, Thomas Knösel, Tanja Paul, Tanja Paul, Stefan Boeck, Stefan Boeck, Christoph Benedikt Westphalen, Christoph Benedikt Westphalen, Christine Spitzweg, Christine Spitzweg, Christoph J. Auernhammer, Christoph J. Auernhammer, Peter Bartenstein, Peter Bartenstein, Lena M. Unterrainer, Leonie Beyer, Leonie Beyer

Get full text